Citations 3
242 | LONG‐TERM EFFICACY AND SURVIVAL OUTCOMES WITH ODRONEXTAMAB IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): 2‐YEAR FOLLOW‐UP FROM THE PHASE 2 ELM‐2 STUDY
Cho, S. , Poon, Michelle, Bachy, E., Guidez, Stéphanie , Jagadeesh, Deepa , Mayer, L, Tani, M., Ambati, Srikanth, Uppala, Amulya , Brouwer‐Visser, Jurriaan , Chaudhry, A., Kim, T. M., Luminari, Stefano , Taszner, Michał , Chong, Geoffrey , Novelli, Silvana , Villasboas, José C. , Merli, Michele , Ubieto, Ana Jiménez , Tessoulin, Benoit , Tucker, David , Walewski, Jan , Yi, S., Song, Yuqin , Alonso, Aránzazu , Iskierka‐Jazdzewska, Elżbieta , Cai, James J. , Shariff, S., Mohamed, Hesham , Kim, Tae Min
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
Patient‐ versus clinician‐reported symptoms in the POLARIX study
Thompson, Carrie A. , Mehta–Shah, Neha , Flowers, Christopher R. , Tilly, Hervé , Chua, Neil , Miall, Fiona , Kim, T. M., Craine, Veronica, Campinha‐Bacote, Avrita, Hirata, J., Sugidono, Matthew , Friedberg, Jonathan W. , Salles, Gilles , Casasnovas, Olivier , Kim, Tae Min , Tsai, Chiao‐Ling , Nasta, Sunita , Lee, S. T., Lee, Cliff
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 414-416
ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) GRADE 1–3A: RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2
Cho, S. , Poon, Michelle, Champion, Rebecca, Guidez, Stéphanie , Jagadeesh, Deepa , Oliveira, Carolina Leite De, Chaudhry, A., Ambati, Srikanth, Kim, T. M., Novelli, Silvana , Luminari, Stefano , Taszner, Michał , Gouill, Steven Le , Villasboas, José C. , Bachy, Emmanuel , Alonso, Aránzazu , Merli, Michele , Tucker, David , Cai, James J. , Zhu, Min , Mohamed, Hesham , Kim, Tae Min
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 121-122